SCHEMBL20176945

SCHEMBL20176945

COc1c(CCN)ccc2c1COC2=O

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KCNJ1 P48048 11/20 0.46
KCNH2 Q12809 5/20 0.46
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HTR2B P41595 2/20 0.40
TAAR1 Q96RJ0 1/20 0.38
IMPDH2 P12268 1/20 0.36
IMPDH1 P20839 1/20 0.36
LMNA P02545 2/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
PDE1A P54750 1/20 0.36
PDE1B Q01064 1/20 0.36
PDE3B Q13370 1/20 0.36
PDE1C Q14123 1/20 0.36
PDE3A Q14432 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20176799 0.81 KCNJ1 (0.68) KCNJ1KCNH2
SCHEMBL20168410 0.77 KCNJ1 (0.44) KCNJ1KCNH2LMNAGAAMAPT
SCHEMBL4110681 0.75 KDM4E (0.57) KCNJ1LMNAMAPTPDE1APDE1B
SCHEMBL20168614 0.75 KCNJ1 (0.50) KCNJ1KCNH2
SCHEMBL20176944 0.75 KCNJ1 (0.50) KCNJ1KCNH2
SCHEMBL30751840 0.74 KCNJ1 (0.44) KCNJ1KCNH2LMNAPDE1APDE1B
SCHEMBL286730 0.74 KCNJ1 (0.44) KCNJ1KCNH2LMNAPDE1APDE1B
SCHEMBL20176843 0.71 KCNJ1 (0.41) KCNJ1KCNH2IMPDH2IMPDH1LMNA
SCHEMBL16836077 0.71 KCNJ1 (0.62) KCNJ1KCNH2
SCHEMBL286450 0.71 KCNJ1 (0.51) KCNJ1KCNH2LMNAPDE1APDE1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3535258-B1 SUBSTITUTED BICYCLE HETEROCYCLIC DERIVATIVES USEFUL AS ROMK CHANNEL INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2021-11-24 EP disclosed
WO-2018093569-A1 SUBSTITUTED BICYCLE HETEROCYCLIC DERIVATIVES USEFUL AS ROMK CHANNEL INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2018-05-24 WO disclosed